stella
beta
Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis — Stella
Recruiting
Back to Palmoplantar Pustulosis (PPP) trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
First Hospital of China Medical University, Shenyang
View full record on ClinicalTrials.gov